33 related articles for article (PubMed ID: 20605240)
1. Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Neumann FJ; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Richardt G;
Heart; 2007 Oct; 93(10):1251-5. PubMed ID: 17890701
[TBL] [Abstract][Full Text] [Related]
2. Twelve-year trends in unprotected left main coronary artery occlusion: insights from a real-world multicentre study.
Alexandre A; Campinas A; Brochado B; Braga M; Sá-Couto D; Santos M; Ribeiro D; Brandão M; Silva MP; de Morais GP; Calvão J; Silva JC; Baggen-Santos R; Luz A; Silveira J; Torres S
ESC Heart Fail; 2024 Mar; ():. PubMed ID: 38549183
[TBL] [Abstract][Full Text] [Related]
3. Comparing the clinical outcomes of single vs. systematic dual stenting strategies for unprotected left main bifurcation lesion: a systematic review and meta-analysis.
Meng S; Kong X; Nan J; Yang X; Li J; Yang S; Zhao L; Jin Z
Front Cardiovasc Med; 2023; 10():1145412. PubMed ID: 37554363
[TBL] [Abstract][Full Text] [Related]
4. Domestic versus imported drug-eluting stents for the treatment of patients with acute coronary syndrome.
Yao HM; Sun TW; Wan YD; Zhang XJ; Fu X; Shen DL; Zhang JY; Li L
World J Emerg Med; 2014; 5(3):175-81. PubMed ID: 25225580
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
6. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
8. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
9. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
Räber L; Magro M; Stefanini GG; Kalesan B; van Domburg RT; Onuma Y; Wenaweser P; Daemen J; Meier B; Jüni P; Serruys PW; Windecker S
Circulation; 2012 Mar; 125(9):1110-21. PubMed ID: 22302840
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.
Park KW; Kang SH; Park KH; Choi DH; Lee HY; Kang HJ; Cho YS; Yeon TJ; Chung WY; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
Int J Cardiol; 2011 Aug; 151(1):89-95. PubMed ID: 20605240
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
De Luca G; Wirianta J; Lee JH; Kaiser C; Di Lorenzo E; Suryapranata H
J Thromb Thrombolysis; 2014 Oct; 38(3):355-63. PubMed ID: 24659172
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.
Park SJ; Kim YH
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1107-14. PubMed ID: 18793113
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
